Jonathan McNeill, Chief Business Officer at Dyne Therapeutics, Inc. (DYN), sold 1,266 shares at $10.41 ($13K) on 2023-09-12, disclosed to the SEC on 2023-09-13.
Seasonal sale ($13k) by Chief Business Officer — this insider has traded DYN in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| DYN | SELL | 2024-08-20 | $122K | — | Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |